Combined elevated midpregnancy tumor necrosis factor alpha and hyperlipidemia in pregnancies resulting in early preterm birth

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 2, 2014, Pages 141.e1-141.e9

  Jelliffe Pawlowski, Laura L ^a,f   Ryckman, Kelli K ^b   Bedell, Bruce ^c   O'Brodovich, Hugh M ^d   Gould, Jeffrey B ^d,e   Lyell, Dierdre J ^d   Borowski, Kristi S ^e   Shaw, Gary M ^d   Murray, Jeffrey C ^c   Stevenson, David K ^d  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e California Perinatal Quality Care Collaborative   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

early preterm birth; hyperlipidemia; term pregnancy; tumor necrosis factor alpha

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANEUPLOIDY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MATERNAL SERUM; NEURAL TUBE DEFECT; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; TERM BIRTH;

EARLY PRETERM BIRTH; HYPERLIPIDEMIA; TERM PREGNANCY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; BODY MASS INDEX; CALIFORNIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; INFANT, NEWBORN; IOWA; LIPIDS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84905089741     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.02.019     Document Type: Article

References (45)

1. R. Romero, M. Mazor, W. Sepulveda, C. Avila, D. Copeland, and J. Williams Tumor necrosis factor in preterm and term labor Am J Obstet Gynecol 166 1992 1576 1587
2. B.D. Pearce, J. Grove, and E.A. Bonney et al. Interrelationship of cytokines, hypothalamic-pituitary-adrenal axis hormones, and psychosocial variables in the prediction of preterm birth Gynecol Obstet Invest 70 2010 40 46
3. M.E. Coussons-Read, M. Lobel, and J.C. Carey et al. The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation Brain Behav Immun 26 2012 650 659
4. M.S. Kramer, S.R. Kahn, and R. Rozen et al. Vasculopathic and thrombophilic risk factors for spontaneous preterm birth Int J Epidemiol 38 2009 715 723
5. L.M. Mudd, C.B. Holzman, J.M. Catov, P.K. Senagore, and R.W. Evans Maternal lipids at mid-pregnancy and the risk of preterm delivery Acta Obstet Gynecol Scand 91 2012 726 735
6. B.W. Alleman, A.R. Smith, and H.M. Byers et al. A proposed method to predict preterm birth using clinical data, standard maternal serum screening, and cholesterol Am J Obstet Gynecol 208 2013 472.e1 472.e11
7. A. Green, S.B. Dobias, D.J. Walters, and A.R. Brasier Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase Endocrinology 134 1994 2581 2588
8. P. Plomgaard, C.P. Fischer, T. Ibfelt, B.K. Pedersen, and H.G. van Tumor necrosis factor-alpha modulates human in vivo lipolysis J Clin Endocrinol Metab 93 2008 543 549
9. X. Yang, X. Zhang, B.L. Heckmann, X. Lu, and J. Liu Relative contribution of adipose triglyceride lipase and hormone-sensitive lipase to tumor necrosis factor-alpha (TNF-alpha)-induced lipolysis in adipocytes J Biol Chem 286 2011 40477 40485
10. H. Ruan, N. Hacohen, T.R. Golub, P.L. Van, and H.F. Lodish Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory Diabetes 51 2002 1319 1336
11. X. Chen, K. Xun, L. Chen, and Y. Wang TNF-alpha, a potent lipid metabolism regulator Cell Biochem Funct 27 2009 407 416
12. C. Lopez-Tinoco, M. Roca, and A. Fernandez-Deudero et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus Cytokine 58 2012 14 19
13. L. Mao, Q. Zhou, S. Zhou, R.R. Wilbur, and X. Li Roles of apolipoprotein E (ApoE) and inducible nitric oxide synthase (iNOS) in inflammation and apoptosis in preeclampsia pathogenesis and progression PLoS One 8 2013 e58168
14. E. Ohmura, D. Hosaka, and M. Yazawa et al. Association of free fatty acids (FFA) and tumor necrosis factor-alpha (TNF-alpha) and insulin-resistant metabolic disorder Horm Metab Res 39 2007 212 217
15. H. Zhang, Y. Park, and J. Wu et al. Role of TNF-alpha in vascular dysfunction Clin Sci (Lond) 116 2009 219 230
16. D.A. Rubin, R.G. McMurray, A.C. Hackney, and J.S. Harrell Relationship between cardiovascular risk factors and adipokines in adolescents Horm Res Paediatr 76 2011 123 129
17. Y.J. Bae, S.H. Kim, and J.H. Chung et al. Evaluation of adiposity-related biomarkers as metabolic syndrome indicators Clin Nutr Res 2 2013 91 99
18. L.L. Jelliffe-Pawlowski, G.M. Shaw, and R.J. Currier et al. Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers Am J Obstet Gynecol 208 2013 492.e1 492.e11
19. J.B. Gould The role of regional collaboratives: the California Perinatal Quality Care Collaborative model Clin Perinatol 37 2010 71 86
20. E.A. Stringer, K.S. Baker, and I.R. Carroll et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology J Transl Med 11 2013 93
21. P. Brizzi, G. Tonolo, and F. Esposito et al. Lipoprotein metabolism during normal pregnancy Am J Obstet Gynecol 181 1999 430 434
22. D. Mankuta, M. Elami-Suzin, A. Elhayani, and S. Vinker Lipid profile in consecutive pregnancies Lipids Health Dis 9 2010 58
23. V. Resi, S. Basu, and M. Haghiac et al. Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy Am J Physiol Endocrinol Metab 303 2012 E832 E840
24. A.H. Moawad, R.L. Goldenberg, and B. Mercer et al. The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth Am J Obstet Gynecol 186 2002 990 996
25. N. Lepage, D. Chitayat, J. Kingdom, and T. Huang Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies Am J Obstet Gynecol 188 2003 1354 1359
26. L. Dugoff, J.C. Hobbins, and F.D. Malone et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial) Am J Obstet Gynecol 191 2004 1446 1451
27. I. Vogel, P. Thorsen, A. Curry, P. Sandager, and N. Uldbjerg Biomarkers for the prediction of preterm delivery Acta Obstet Gynecol Scand 84 2005 516 525
28. N. Vitoratos, K. Papadias, E. Makrakis, G. Christodoulakos, K. Panoulis, and G. Creatsas Association between serum tumor necrosis factor-alpha and corticotropin-releasing hormone levels in women with preterm labor J Obstet Gynaecol Res 32 2006 497 501
29. J.M. Catov, L.M. Bodnar, and K.E. Kip et al. Early pregnancy lipid concentrations and spontaneous preterm birth Am J Obstet Gynecol 197 2007 610 617
30. A.E. Curry, I. Vogel, and C. Drews et al. Mid-pregnancy maternal plasma levels of interleukin 2, 6, and 12, tumor necrosis factor-alpha, interferon-gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery Acta Obstet Gynecol Scand 86 2007 1103 1110
31. T. Gunes, E. Koklu, and M.A. Ozturk Maternal and cord serum lipid profiles of preterm infants with respiratory distress syndrome J Perinatol 27 2007 415 421
32. R. Smith, J.I. Smith, and X. Shen et al. Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor J Clin Endocrinol Metab 94 2009 2066 2074
33. L. Dugoff First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes Obstet Gynecol 115 2010 1052 1061
34. M.S. Kramer, S.R. Kahn, and R.W. Platt et al. Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birth Cytokine 49 2010 10 14
35. E.B. Magnussen, L.J. Vatten, K. Myklestad, K.A. Salvesen, and P.R. Romundstad Cardiovascular risk factors prior to conception and the length of pregnancy: population-based cohort study Am J Obstet Gynecol 204 2011 526 528
36. P. Tsiartas, R.M. Holst, and U.B. Wennerholm et al. Prediction of spontaneous preterm delivery in women with threatened preterm labour: a prospective cohort study of multiple proteins in maternal serum BJOG 119 2012 866 873
37. M.J. Stout, K.R. Goetzinger, M.G. Tuuli, A.G. Cahill, G.A. Macones, and A.O. Odibo First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth Placenta 34 2013 14 19
38. R.B. Harris Direct and indirect effects of leptin on adipocyte metabolism Biochim Biophys Acta 1842 2014 414 423
39. H. Bohler Jr., S. Mokshagundam, and S.J. Winters Adipose tissue and reproduction in women Fertil Steril 94 2010 795 825
40. M. Amitani, A. Asakawa, H. Amitani, and A. Inui The role of leptin in the control of insulin-glucose axis Front Neurosci 7 2013 51
41. H. Ruan, and H.F. Lodish Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha Cytokine Growth Factor Rev 14 2003 447 455
42. S. Bansal, J.E. Buring, N. Rifai, S. Mora, F.M. Sacks, and P.M. Ridker Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 2007 309 316
43. D. Sidhu, and C. Naugler Fasting time and lipid levels in a community-based population: a cross-sectional study Arch Intern Med 172 2012 1707 1710
44. J.M. Gaziano Should we fast before we measure our lipids? Arch Intern Med 172 2012 1705 1706
45. A.V. Khera, and S. Mora Fasting for lipid testing: Is it worth the trouble? Arch Intern Med 172 2012 1710 1712